Pain Cancer Clinical Trial
Official title:
Study of the Effectiveness of Ultrasound-guided Percutaneous Neuromodulation Versus Pharmacological Treatment in Oncology Patients With Anterior Knee Pain
the goal of this clinical trial is to compare in cancer patients: Is ultrasound-guided percutaneous neuromodulation useful for Anterior Knee Pain relief in cancer patients? Participants will receive treatments of ultrasound-guided percutaneous neuromodulation and pharmacological treatment Researchers will compare ultrasound-guided percutaneous neuromodulation versus pharmacological treatment to see if Anterior Knee Pain is reduced
Unhealthy lifestyles, an aging population and increased life expectancy increase the likelihood of cancer. Knee pain is one of the most common symptoms that cause functional incapacity, which requires the search and improvement of its assessment, prevention and treatment tools. Physiotherapists are currently using ultrasound-guided Percutaneous Neuromodulation clinically. It is an easy process to perform, non-invasive, safe and economical. Traditional therapies have been and will continue to be useful. The decrease in manufacturing costs of assessment tools such as ultrasound and neuromodulator treatment in recent years has made the acquisition of these equipment as intervention tools economical. This is because they have been shown to be useful for improving function and reducing pain. Opioid analgesics are the main option for pain treatment in cancer patients, but their side effects and inadequate treatment lead to cheaper, quicker options with lower risk of addiction and/or side effects. In order to improve these symptoms, it is essential to have an objective knowledge of the changes produced by neuromodulation and to be able to measure the variation of pain experienced by patients. It has been demonstrated in recent years that assessment tools such as ultrasound and myotonometer are very useful, safe and non-invasive procedures, both have been consolidated as assessment tools that can evaluate changes and analyze the contractile properties of soft tissue quickly and safely. There are abundant literature on this subject. Therefore, researchers suggest conducting research that improves and provides new data on the efficacy and effectiveness of treatment of ultrasound-guided percutaneous neuromodulation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Suspended |
NCT05067257 -
Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer
|
Phase 2 | |
| Recruiting |
NCT06160323 -
Upfront EUS CGN/CPN vs Conventional Step up Approach for Inoperable Painful Pancreatic Cancer
|
N/A | |
| Terminated |
NCT04872556 -
Evaluation of the Effect of Laser Acupuncture on Taxane Acute Pain Syndrome Patients
|
N/A | |
| Recruiting |
NCT05236647 -
Subcutaneous Versus Intravenous Morphine When Switching From Oral to Parenteral Route in Palliative Cancer Patients
|
Phase 3 | |
| Not yet recruiting |
NCT04782206 -
S3 Root Pulsed Radiofrequency Added to Superior Hypogstric Plexus Block
|
N/A | |
| Not yet recruiting |
NCT06240377 -
Effectiveness of NMP and TDCS vs Pharmacological Treatment in Cancer Patients With Lower Limb Pain
|
N/A | |
| Recruiting |
NCT05450419 -
The Role of Vitamin D3 Supplementation in Advanced Cancer Patients With Pain
|
N/A | |
| Recruiting |
NCT06101849 -
Chronic Cancer Pain Management Program
|
N/A | |
| Recruiting |
NCT05299047 -
Fluoroscopic Anterior Approach Versus Ultrasound Guided Superior Hypogastric Plexus Neurolysis in Cancer Pelvic Pain
|
Phase 2 | |
| Withdrawn |
NCT04572776 -
Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain
|
Phase 3 | |
| Recruiting |
NCT03297723 -
Effectiveness of a Patient Therapeutic Education Program in Improving Pain Management
|